Fluorescently Labeled Bevacizumab in Human Breast Cancer - Defining the Classification Threshold

CLINICAL AND PRECLINICAL OPTICAL DIAGNOSTICS（2017）

引用 0|浏览2

暂无评分

摘要

In-vivo fluorescently labelled drug (bevacizumab) breast cancer specimen where obtained from patients. We propose a new structured method to determine the optimal classification threshold in targeted fluorescence intra-operative imaging.

查看译文

关键词

Imaging systems, Medical and biological imaging, Clinical applications

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要